Maynard Ryan D has filed 11 insider transactions across 3 companies since February 2023.
Most recent transaction: a grant/award of 400000 shares of Foghorn Therapeutics Inc. ($FHTX) on February 23, 2026.
Activity breakdown: 0 open-market purchases and 2 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 23, 2026 | Foghorn Therapeutics Inc. | $FHTX | Maynard Ryan D | Chief Financial Officer | A | Stock Option (right to buy) | 400000 | $5.75 | 400,000.0000 | 63,029,293 | 9999.99% | 0.63% |
| June 13, 2025 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | Maynard Ryan D | Director | A | Deferred Restricted Stock Unit | 67546 | $0.00 | 67,546.0000 | 322,868 | 9999.99% | 20.92% |
| Nov. 12, 2024 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | Maynard Ryan D | Director | S | Common Stock | 50000 | $10.06 | 7,500.0000 | 303,269 | 86.96% | 16.49% |
| Nov. 12, 2024 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | Maynard Ryan D | Director | M | Stock Option (right to buy) | 50000 | $0.00 | 0.0000 | 303,269 | 100.00% | 16.49% |
| Nov. 12, 2024 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | Maynard Ryan D | Director | M | Common Stock | 50000 | $7.45 | 57,500.0000 | 303,269 | 666.67% | 16.49% |
| June 11, 2024 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | Maynard Ryan D | Director | A | Deferred Restricted Stock Unit | 49303 | $0.00 | 49,303.0000 | 266,220 | 9999.99% | 18.52% |
| March 1, 2024 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | Maynard Ryan D | Director | A | Deferred Restricted Stock Unit | 50000 | $0.00 | 50,000.0000 | 235,131 | 9999.99% | 21.27% |
| Feb. 8, 2023 | Tvardi Therapeutics, Inc. | $TVRD | Maynard Ryan D | CHIEF FINANCIAL OFFICER | S | Common Stock | 5488 | $0.53 | 8,012.0000 | 4,471,130 | 40.65% | 0.12% |
| Feb. 1, 2024 | Tvardi Therapeutics, Inc. | $TVRD | Maynard Ryan D | CHIEF FINANCIAL OFFICER | A | Common Stock | 13500 | $0.00 | 13,500.0000 | 4,512,422 | 9999.99% | 0.30% |
| June 6, 2023 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | Maynard Ryan D | Director | A | Deferred Restricted Stock Unit | 51955 | $0.00 | 51,955.0000 | 213,694,000 | 9999.99% | 0.02% |
| March 1, 2023 | Tvardi Therapeutics, Inc. | $TVRD | Maynard Ryan D | Chief Financial Officer | A | Stock Option (Right to Buy) | 81000 | $0.00 | 81,000.0000 | 4,471,130 | 9999.99% | 1.81% |